Bi-lateral HGN Therapy in Real-World Patients -Post Approval Research Investigation
NCT: NCT07331285 · RECRUITING
Brief Summary
The objective of the BREATHE study is to demonstrate the continued safety and effectiveness of the Genio® System in treating subjects diagnosed with moderate to severe obstructive sleep apnea (OSA) who are intolerant to or failed/refused PAP treatments.
Frequently Asked Questions
What is Bi-lateral HGN Therapy in Real-World Patients -Post Approval Research Investigation?
Bi-lateral HGN Therapy in Real-World Patients -Post Approval Research Investigation is a clinical trial registered under NCT07331285. Current status: RECRUITING.
What is the status of NCT07331285?
The current status of NCT07331285 (Bi-lateral HGN Therapy in Real-World Patients -Post Approval Research Investigation) is: RECRUITING.
When did Bi-lateral HGN Therapy in Real-World Patients -Post Approval Research Investigation start?
Bi-lateral HGN Therapy in Real-World Patients -Post Approval Research Investigation started on 2026-06.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.